ArticleJournal of medicinal chemistry2025

Design, Optimization, and Development of RIPK1 Degraders with Improved Pharmacokinetic and Pharmacodynamic Properties.

Dong Lu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.